Influenza

Overcoming Challenges to Create a Universal Influenza Vaccine

By

Jasenka Piljac Žegarac, PhD

Researchers from the National Institute of Allergy and Infectious Diseases are working to develop a universal influenza vaccine.

Safety and Efficacy: IV Zanamivir vs Oral Oseltamivir in Severe Influenza

By

Cindy Lampner

Intravenous zanamivir is as safe and effective as oral oseltamivir when used in patients with severe influenza.

High-Dose Flu Vaccine More Effective for Patients With HIV

By

Bradley van Paridon

Study authors assessed the effectiveness of high-dose influenza vaccines in patients with HIV during the 2017-2018 influenza season.

Egg- And Cell-Derived Influenza Vaccines Elicit Similar Antibody Responses

By

Zahra Masoud

Investigators conducted a randomized, open-label trial during the 2018-2019 influenza season to assess neutralization titers in pre- and post-immunization sera from 133 adults immunized with one of three types of influenza vaccines.

Only Two-Thirds of Parents Planning to Get Influenza Vaccines for Their Children

One-third of parents say they will forgo influenza vaccination for their children this year, despite public health recommendations.

Disparities in Influenza Vaccination Among Adults With Cardiovascular Disease

By

Bradley van Paridon

Researchers evaluated prevalence of and sociodemographic disparities in influenza vaccination among individuals with ASCVD.

Flu Activity Low in Southern Hemisphere From June to August 2020

There was very low influenza activity from June to August 2020 in the Southern Hemisphere.

COVID-19: Influenza Vaccine Key in Mitigating Healthcare Burden During Flu Season

By

Zahra Masoud

During the upcoming flu season, it is essential to ensure a high coverage rate of vaccination, particularly among populations who are vulnerable to COVID-19.

Pimodivir Influenza Development Program Discontinued

By

Brian Park, PharmD

The efficacy and safety of pimodivir, an inhibitor of influenza virus polymerase basic protein 2, was being investigated in two phase 3 studies.

Risk Factors for Cardiovascular Events in Adults Hospitalized With Influenza

Acute heart failure and acute ischemic heart disease are most common cardiovascular events in adults hospitalized with influenza.